Suicide Prevention by Lithium (SUPLI) - Challenges of a multi-center prospective study

Erik Lauterbach*, Bernd Ahrens, Werner Felber, Bruno Muller-Oerlinghausen, Birgit Kilb, Gerd Bischof, Isabella Heuser, Petra Werner, Barbara Hawellek, Wolfgang Maier, Ute Lewitzka, Oliver Pogarell, Ulrich Hegerl, Thomas Bronisch, Kneginja Richter, Günther Niklewski, Andreas Broocks, Fritz Hohagen

*Corresponding author for this work
    15 Citations (Scopus)


    Several studies have shown that there is a significantly increased risk of suicide related mortality in patients with a positive history of suicide attempts. The SUPLI-Study is the first prospective, randomized, double blind, placebo controlled multi-center trial focusing on the proposed suicide preventive effects of lithium in patients with suicidal behavior but not suffering from bipolar disorder or recurrent major depressive disorder. Patients with a recent history of a suicide attempt are treated with lithium versus placebo during a 12 month period. The hypothesis is that lithium treatment will lead to a 50% reduction of suicidal behavior. The protocol of the study and preliminary results an presented.

    Original languageEnglish
    JournalArchives of Suicide Research
    Issue number1
    Pages (from-to)27-34
    Number of pages8
    Publication statusPublished - 2005

    Research Areas and Centers

    • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


    Dive into the research topics of 'Suicide Prevention by Lithium (SUPLI) - Challenges of a multi-center prospective study'. Together they form a unique fingerprint.

    Cite this